ArticleOpen life sciences2026

Irofulven and RSL3 synergistically target ferroptosis-related gene PTGR1 to treat head and neck squamous cell carcinoma.

Xiyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.